pDisplay-EGFP-2A-HA-Nrxn3-alpha- 2(-)/3(+)/4(+)/6(-)-GPI
(Plasmid
#184335)
-
PurposeExpression of GPI-anchored form of mouse Nrx3-alpha containing the alternative splice site 5 together with EGFP protein separated by 2A peptide. Contains insertions at alternatively splice sites 1,3,
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 184335 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepDisplay-AP-CFP-TM
-
Backbone manufacturerAlice Ting Lab / Addgene_#20861
-
Modifications to backboneEGFP-2A was inserted after the CMV promoter in frame with the signal peptide
-
Vector typeMammalian Expression
-
Selectable markersNeomycin (select with G418)
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameNrxn3-alpha-GPI
-
SpeciesM. musculus (mouse)
-
Insert Size (bp)4179
-
Entrez GeneNrxn3
- Promoter CMV
-
Tag
/ Fusion Protein
- HA-tag (N terminal on insert)
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site BglII (not destroyed)
- 3′ cloning site XhoI (not destroyed)
- 5′ sequencing primer T7
- 3′ sequencing primer BGH-rev (Common Sequencing Primers)
Resource Information
-
Supplemental Documents
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pDisplay-EGFP-2A-HA-Nrxn3-alpha- 2(-)/3(+)/4(+)/6(-)-GPI was a gift from Peter Scheiffele (Addgene plasmid # 184335 ; http://n2t.net/addgene:184335 ; RRID:Addgene_184335) -
For your References section:
Targeted proteoform mapping uncovers specific Neurexin-3 variants required for dendritic inhibition. Hauser D, Behr K, Konno K, Schreiner D, Schmidt A, Watanabe M, Bischofberger J, Scheiffele P. Neuron. 2022 May 8. pii: S0896-6273(22)00362-2. doi: 10.1016/j.neuron.2022.04.017. 10.1016/j.neuron.2022.04.017 PubMed 35550065